Recall: The pain medication in the bottle doesn’t match the label on the bottle

·1 min read

A dangerous packaging mistake caused Bryant Ranch Prepack to recall 500 mg tablets of Methocarbamol, the generic form of muscle relaxer/pain medication Robaxin.

Bryant is recalling one lot of 30-count, 60-count and 90-count bottles. While the bottles are labeled as having 500 mg tablets, the tablets are 750 mg strength.

As the Bryant-written, FDA-posted recall notice says: “If a patient takes a 750mg tablet of Methocarbamol instead of the prescribed 500mg tablets, it potentially could result in excessive central nervous system depression which may result in nausea, sedation, fainting, falls, seizure, coma, and death.”

All three recalled count numbers have lot No. 163935 with expiration date 10/22.

The label of Bryant Ranch Prepack’s recalled 60-count bottles of Methocarbamol
The label of Bryant Ranch Prepack’s recalled 60-count bottles of Methocarbamol

If you’re a distributor or wholesaler, set aside that lot and contact Bryant to return the tablets.

If you’re a consumer, stop using the recalled tablets, return them to the pharmacy where you got them, ask for a refund and contact your doctor.

For questions about the recall, email compliance@brpharma.com or call Bryant at 877-885-0882, Monday through Friday, 10 a.m. to 9 p.m., Eastern time.

If this or any drug causes a problem, after notifying a medical professional, let the FDA know via its MedWatch Adverse Event page or by filling out a form you can get by calling 800-332-1088.

Heart procedure needles recalled after ‘complaints of rust.’ Use ‘may lead to death’

Second recall of anesthetic for issue that can cause ‘severe morbidity, even death’

Hand sanitizer brand has ‘unacceptable levels’ of cancer-causing chemicals, FDA warns

Two kinds of blood pressure medication recalled for possibly too much of a carcinogen

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting